CDK4/6 inhibitors arrest the cell cycle in G1‐phase. They are approved to treat breast cancer and are also undergoing clinical trials against a range of other tumour types. To …
R Foy, L Crozier, AU Pareri, JM Valverde, BH Park… - Molecular Cell, 2023 - cell.com
CDK4/6 inhibitors are remarkable anti-cancer drugs that can arrest tumor cells in G1 and induce their senescence while causing only relatively mild toxicities in healthy tissues. How …
M Wade - Journal of biomolecular screening, 2015 - journals.sagepub.com
The clustered regularly interspaced short palindromic repeats (CRISPR)/Cas system has been seized upon with a fervor enjoyed previously by small interfering RNA (siRNA) and …
Protecting stalled DNA replication forks from degradation by promiscuous nucleases is essential to prevent genomic instability, a major driving force of tumorigenesis. Several …
R Goold, J Hamilton, T Menneteau, M Flower… - Cell reports, 2021 - cell.com
CAG repeat expansion in the HTT gene drives Huntington's disease (HD) pathogenesis and is modulated by DNA damage repair pathways. In this context, the interaction between …
Ubiquitin-fold modifier 1 (UFM1) is involved in neural and erythroid development, yet its biological roles in these processes are unknown. Here, we generated zebrafish models …
C Lachaud, A Moreno, F Marchesi, R Toth, JJ Blow… - Science, 2016 - science.org
Mono-ubiquitination of Fancd2 is essential for repairing DNA interstrand cross-links (ICLs), but the underlying mechanisms are unclear. The Fan1 nuclease, also required for ICL …
S Strickson, CH Emmerich, ETH Goh… - Proceedings of the …, 2017 - National Acad Sciences
It is widely accepted that the essential role of TRAF6 in vivo is to generate the Lys63-linked ubiquitin (K63-Ub) chains needed to activate the “master” protein kinase TAK1. Here, we …
Homeodomain interacting protein kinase-2 (HIPK2) is a member of the HIPK family of stress- responsive kinases that modulates cell growth, apoptosis, proliferation and development …